comments feed

By Cheryl Miller, From The Recorder SACRAMENTO—Genentech Inc. and OSI Pharmaceuticals LLC will pay a combined $67 million to resolve allegations that they overstated the ability of the drug Tarceva to treat certain non-small cell lung cancer patients, the U.S. Attorney’s Office for the Northern District of California said Monday. Genentech, based in South San Francisco, […]